Cargando…

Tumor cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers

Detalles Bibliográficos
Autores principales:	Cleary, Allison S., Leonard, Travis L., Gestl, Shelley A., Gunther, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050741/ https://www.ncbi.nlm.nih.gov/pubmed/24695311 http://dx.doi.org/10.1038/nature13187

Ejemplares similares

Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer
por: Keller, Ross R., et al.
Publicado: (2019)

Breast Tumors Maintain a Reservoir of Subclonal Diversity During Expansion
por: Minussi, Darlan Conterno, et al.
Publicado: (2021)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies
por: Parisi, Fabio, et al.
Publicado: (2011)

Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
por: Janiszewska, Michalina, et al.
Publicado: (2019)

Accurate Identification of Subclones in Tumor Genomes
por: Ahmadinejad, Navid, et al.
Publicado: (2022)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
por: Rampias, Theodoros
Publicado: (2020)

Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice
por: Watanabe, Kazuhide, et al.
Publicado: (2013)

Exosomal Wnt7a from a low metastatic subclone promotes lung metastasis of a highly metastatic subclone in the murine 4t1 breast cancer
por: Li, Chunning, et al.
Publicado: (2022)

Heterogeneity and proliferation of invasive cancer subclones in game theory models of the Warburg effect
por: Archetti, M.
Publicado: (2015)

DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing
por: Zhou, Zilu, et al.
Publicado: (2020)

Deconstructing the intra-tumor subclonal heterogeneity of lung synchronous ground-glass nodules using whole-genome sequencing
por: Ren, Yijiu, et al.
Publicado: (2022)

A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2023)

Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001)

Subclonal reconstruction of tumors using machine learning and population genetics
por: Caravagna, Giulio, et al.
Publicado: (2020)

The Wnt Receptor, Lrp5, Is Expressed by Mouse Mammary Stem Cells and Is Required to Maintain the Basal Lineage
por: Badders, Nisha M., et al.
Publicado: (2009)

CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data
por: Yu, Zhenhua, et al.
Publicado: (2016)

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
por: Karaayvaz, Mihriban, et al.
Publicado: (2018)

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
por: Poglio, Sandrine, et al.
Publicado: (2020)

Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
por: Färber, Benedikt, et al.
Publicado: (2023)

Wnt signalling in mammary carcinogenesis
por: Speirs, Valerie
Publicado: (2002)

TrAp: a tree approach for fingerprinting subclonal tumor composition
por: Strino, Francesco, et al.
Publicado: (2013)

MixClone: a mixture model for inferring tumor subclonal populations
por: Li, Yi, et al.
Publicado: (2015)

SeqClone: sequential Monte Carlo based inference of tumor subclones
por: Ogundijo, Oyetunji E., et al.
Publicado: (2019)

Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
por: Giessler, Klara M., et al.
Publicado: (2017)

A community effort to create standards for evaluating tumor subclonal reconstruction
por: Salcedo, Adriana, et al.
Publicado: (2020)

Paracrine Behaviors Arbitrate Parasite-Like Interactions Between Tumor Subclones
por: Noble, Robert J., et al.
Publicado: (2021)

CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data
por: Yu, Zhenhua, et al.
Publicado: (2017)

Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation
por: Kok, Sau Yee, et al.
Publicado: (2021)

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer
por: Hou, Zelin, et al.
Publicado: (2023)

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016)

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors
por: Paul, Ritama, et al.
Publicado: (2020)

TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors
por: Nieboer, Marleen M., et al.
Publicado: (2018)

Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer
por: Ryu, Daeun, et al.
Publicado: (2023)

Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity
por: Cicchini, Michelle, et al.
Publicado: (2014)

Biased estimates of clonal evolution and subclonal heterogeneity can arise from PCR duplicates in deep sequencing experiments
por: Smith, Erin N, et al.
Publicado: (2014)

Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
por: Chapman, Anna, et al.
Publicado: (2014)

Analytical subcloning of a clonal cell line demonstrates cellular heterogeneity that does not impact process consistency or robustness
por: Scarcelli, John J., et al.
Publicado: (2018)

Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21(R110) chronic lymphocytic leukemia
por: Paschold, Lisa, et al.
Publicado: (2022)

Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ndp2pjtlc7jvmqahsf31u2sao6